W BRADFORD MIDDLEKAUFF Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for W BRADFORD MIDDLEKAUFF.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of W BRADFORD MIDDLEKAUFF. W BRADFORD MIDDLEKAUFF is a SVP, General Counsel & Sec. in MEDAREX INC ($MEDX) and a Senior VP, GC and Secretary in Edge Therapeutics, Inc. ($EDGE) and a General Counsel in Health Sciences Acquisitions Corp ($HSAC).
Address: MEDAREX, INC. 707 STATE ROAD PRINCETON 08540 NJ
Companies in which W BRADFORD MIDDLEKAUFF is an Insider
Immunovant, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of W BRADFORD MIDDLEKAUFF: General Counsel
Holdings: 0 shares
Latest Transaction: May 18 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MEDAREX INC
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of W BRADFORD MIDDLEKAUFF: SVP, General Counsel & Sec.
Holdings: 3,000 shares
Latest Transaction: Sep 05 2007
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PDS Biotechnology Corp
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of W BRADFORD MIDDLEKAUFF: Senior VP, GC and Secretary
Holdings: 59,766 shares
Current Value: $570,765
Latest Transaction: Mar 18 2019
$EDGE Market Capitalization: $272.98M
$EDGE Previous Close: $9.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of W BRADFORD MIDDLEKAUFF
Sentiment: All, IMVT, MEDX, EDGE
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 18 2020 | HSAC | Immunovant, Inc. | MIDDLEKAUFF W BRADFORD | General Counsel | Option Exercise | A | 19.01 | 142,600 | 2,710,826 | 142,600 | |
| Dec 20 2019 | HSAC | Health Sciences Ac ... | MIDDLEKAUFF W BRADFORD | General Counsel | Option Exercise | A | 7.86 | 489 | 3,844 | 489 | |
| Dec 20 2019 | HSAC | Health Sciences Ac ... | MIDDLEKAUFF W BRADFORD | General Counsel | Option Exercise | A | 7.86 | 211,277 | 1,660,637 | 211,277 | |
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | MIDDLEKAUFF W BRADFORD | Senior VP, GC and S ... | Option Exercise | M | 0.00 | 49,766 | 0 | 0 | |
| Mar 18 2019 | EDGE | Edge Therapeutics, ... | MIDDLEKAUFF W BRADFORD | Senior VP, GC and S ... | Buy | M | 0.00 | 49,766 | 0 | 59,766 | 10 K to 59.8 K (+497.66 %) |
| Aug 15 2018 | EDGE | Edge Therapeutics, ... | MIDDLEKAUFF W BRADFORD | Senior VP, GC and S ... | Option Exercise | A | 0.00 | 49,766 | 0 | 49,766 | |
| Mar 05 2018 | EDGE | Edge Therapeutics, ... | MIDDLEKAUFF W BRADFORD | Senior VP, GC and S ... | Option Exercise | A | 14.98 | 65,000 | 973,700 | 65,000 |